RANIERI, ELENA
 Distribuzione geografica
Continente #
NA - Nord America 8.780
EU - Europa 7.391
AS - Asia 4.875
SA - Sud America 621
Continente sconosciuto - Info sul continente non disponibili 544
AF - Africa 67
OC - Oceania 6
Totale 22.284
Nazione #
US - Stati Uniti d'America 8.652
CN - Cina 1.853
IE - Irlanda 1.649
SG - Singapore 1.595
UA - Ucraina 1.100
IT - Italia 992
RU - Federazione Russa 913
SE - Svezia 858
DE - Germania 611
BR - Brasile 508
FR - Francia 476
HK - Hong Kong 418
FI - Finlandia 375
IN - India 295
TR - Turchia 251
VN - Vietnam 207
GB - Regno Unito 150
CA - Canada 62
CZ - Repubblica Ceca 60
BD - Bangladesh 59
NL - Olanda 55
MX - Messico 36
AR - Argentina 35
BE - Belgio 34
JP - Giappone 30
AT - Austria 28
ES - Italia 27
IQ - Iraq 26
PL - Polonia 24
ZA - Sudafrica 22
EC - Ecuador 19
PK - Pakistan 19
CL - Cile 14
PH - Filippine 13
VE - Venezuela 13
PY - Paraguay 12
AZ - Azerbaigian 11
ID - Indonesia 11
JO - Giordania 11
LT - Lituania 11
MA - Marocco 11
UZ - Uzbekistan 11
SA - Arabia Saudita 10
EU - Europa 9
CO - Colombia 8
KE - Kenya 8
MY - Malesia 8
AE - Emirati Arabi Uniti 6
IR - Iran 6
ET - Etiopia 5
GT - Guatemala 5
HN - Honduras 5
IL - Israele 5
JM - Giamaica 5
RO - Romania 5
UY - Uruguay 5
EG - Egitto 4
LB - Libano 4
PE - Perù 4
TH - Thailandia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AU - Australia 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
GE - Georgia 3
HR - Croazia 3
NP - Nepal 3
NZ - Nuova Zelanda 3
OM - Oman 3
PT - Portogallo 3
TN - Tunisia 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
CH - Svizzera 2
CI - Costa d'Avorio 2
CM - Camerun 2
DZ - Algeria 2
KW - Kuwait 2
NG - Nigeria 2
NI - Nicaragua 2
QA - Qatar 2
SI - Slovenia 2
SR - Suriname 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
AO - Angola 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CG - Congo 1
DM - Dominica 1
GA - Gabon 1
GR - Grecia 1
HU - Ungheria 1
IM - Isola di Man 1
KH - Cambogia 1
KR - Corea 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MD - Moldavia 1
Totale 21.739
Città #
Dublin 1.649
San Jose 1.367
Chandler 999
Singapore 800
Jacksonville 773
Ashburn 571
Nyköping 548
Dearborn 541
Hong Kong 413
Munich 412
Nanjing 380
Beijing 344
Dallas 249
New York 240
Wilmington 239
Santa Clara 238
Helsinki 206
Council Bluffs 183
Princeton 181
Lauterbourg 169
San Mateo 157
Nanchang 145
Columbus 124
Ann Arbor 122
Boardman 119
Moscow 117
Foggia 98
Shenyang 85
Woodbridge 83
The Dalles 80
Bari 79
Los Angeles 77
Des Moines 74
Ho Chi Minh City 72
Tianjin 69
Hebei 68
Milan 67
Rome 58
Brno 53
Seattle 53
Kunming 51
Hanoi 47
Jiaxing 45
Changsha 44
São Paulo 38
Pune 37
Hangzhou 34
Shanghai 33
Jinan 30
Brussels 29
Falls Church 29
Guangzhou 28
Tokyo 27
Toronto 27
Brooklyn 25
Hilden 25
Zhengzhou 25
Ningbo 23
San Francisco 22
Augusta 20
Frankfurt am Main 20
Naples 20
Warsaw 20
London 19
Rio de Janeiro 19
Houston 18
Noci 17
Norwalk 17
Taizhou 17
Changchun 16
Lanzhou 16
Atlanta 15
Fuzhou 15
Phoenix 15
Stevenage 15
Belo Horizonte 14
Chicago 14
Florence 14
Orem 14
Auburn Hills 13
Hillsboro 12
Manchester 12
Mexico City 12
Nuremberg 12
Chennai 11
Paris 11
Turku 11
Vienna 11
Catania 10
Manfredonia 10
Saint Petersburg 10
Stockholm 10
Amman 9
Baghdad 9
Baku 9
Bologna 9
Boston 9
Falkenstein 9
Haiphong 9
Johannesburg 9
Totale 13.473
Nome #
L’aumento del tessuto adiposo peri- e para-renale si correla con la sindrome metabolica e con la presenza di lesioni da glomerulopatia correlata all’obesità 519
Angiotensin IV stimulates plasminogen activator inhibitor-1 expression in proximal tubular epithelial cells 283
Branchio-Oto-Renal Syndrome (BOR) associated with focal glomerulosclerosis in a patient with a novel EYA1 splice site mutation 278
Metodo per il dosaggio del fattore di crescita epidermico (EGF) e del peptide-1 chemiotattico dei monociti umani (MCP-1) in un campione biologico e relativo kit diagnostico 268
CD8+ cytotoxic T lymphocytes isolated from allogeneic healthy donors recognize HLA class Ia/Ib-associated renal carcinoma antigens with ubiquitous or restricted tissue expression 257
miR-29b and miR-198 overexpression in CD8+ T cells of renal cell carcinoma patients down-modulates JAK3 and MCL-1 leading to immune dysfunction 187
Biosynthesis of C3 by human mesangial cells. Modulation by proinflammatory cytokines. 177
A type I interferon signature characterizes chronic antibody-mediated rejection in kidney transplantation 172
Activated coagulation factor X: a novel mitogenic stimulus for human mesangial cells 169
Tumori del rene e della via urinaria: cosa deve sapere il nefrologo 167
The role of alpha-smooth muscle actin and platelet-derived growth factor-beta receptor in the progression of renal damage in human IgA nephropathy. 166
L’aumento del tessuto adiposo peri- e para-renale si correla con la sindrome metabolica e con la presenza di lesioni da glomerulopatia correlata all’obesità. 164
L’aumento del tessuto adiposo peri- e para-renale si correla con la sindrome metabolica e con la presenza di lesioni da glomerulopatia correlata all’obesità 163
GLI INIBITORI DELLA TRASCRITTASI INVERSA (RT) DOWN-REGOLANO LA PROLIFERAZIONE CELLULARE E INDUCONO IL DIFFERENZIAMENTO NEL CARCINOMA RENALE A CELLULE CHIARE. 162
Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma 162
High glucose concentration induces the overexpression of transforming growth factor-beta through the activation of a platelet-derived growth factor loop in human mesangial cells. 161
Pentraxin 3: A novel biomarker for predicting progression from prostatic inflammation to prostate cancer 161
cell carcinoma cell line and use thereof. 158
The ratio of epidermal growth factor to monocyte chemotactic peptide-1 in the urine predicts renal prognosis in IgA nephropathy. 154
Trapidil inhibits human mesangial cells proliferation: effect on PDGF-β receptor binding and expression 154
CD2AP mutations are associated with sporadic nephrotic sindrome and focal segmental glomerulosclerosis (FSGS). 153
Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma 151
Interleukin-6, interleukin-8 and monocyte chemotactic peptide-1 gene expression and protein synthesis are independently modulated by hemodialysis membranes 149
WAIT AND SEE: IS IT A POSSIBLE OPTION IN ASYMPTOMATIC PATIENTS WITH MESH EXPOSURE? 149
Establishment and characterization of a highly immunogenic human renal carcinoma cell line 148
Additive effect of cyclosporine and low density lipoproteins on transforming growth factor-beta 1 and monocyte chemotactic protein-1 expression in human mesangial cells. 143
Soluble Serum αKlotho Is a Potential Predictive Marker of Disease Progression in Clear Cell Renal Cell Carcinoma 143
AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD): PKD1 AND PKD2 MUTATIONAL SCREENING IN 100 ITALIAN PATIENTS 141
IgA nephropathy: pros and cons for a familial disease. 140
Renal cortical complement C3 gene expression in IgA nephropathy 140
Atti 52° Congresso Nazionale della Società Italiana di Nefrologia. Genova, 21-24 Settembre, 2011 140
Jak3 mutations predict poor survival in patients with clear cell renal carcinoma 139
BEAT: Bioinformatics Exon Array Tool to store, analyze and visualize Affymetrix GeneChip Human Exon Array data from disease experiments. 138
“Concentrazioni urinarie di EGF (epidermal growth factor) urinario in bambini affetti da grave uropatia ostruttiva e da reflusso”. 137
REVERSE TRANSCRIPTASE (RT) INHIBITORS INDUCE DIFFERENTIATION AND UPREGULATE MHC CLASS I IN HUMAN RENAL CLEAR CELL CARCINOMA. 135
CD40L proinflammatory and profibrotic effects on proximal tubular epithelial cells: role of NF-kappaB and lyn. 135
[Anti-phospholipase A2 receptor (anti-PLA2R) antibodies and idiopathic membranous nephropathy: which role in diagnosis and prognosis of this disease?] 135
Abnormalities of the IgA immune system in members of unrelated pedigrees from patients with IgA nephropathy. 134
ESCREZIONE URINARIA DI MONOCYTE CHEMOTACTIC PEPTIDE-1 ED EPIDERMAL GROWTH FACTOR NELL’UROPATIA OSTRUTTIVA IN ETÀ PEDIATRICA 134
“Urinary excretion and renal expression of monocyte chemotactive peptide-1 (MCP-1) and epidermal growth factor expression (EGF) in children with reflux and obstructive nephropathies 134
Renal and upper urinary tract tumors: what the nephrologist should know 133
Protease-activated receptor 1 and plasminogen activator inhibitor 1 expression in chronic allograft nephropathy. 133
Renal Carcinoma Cell Line and Use Thereof 132
Espressione renale di epidermal growth factor (EGF) e monocyte chemotactic peptide-1 (MCP-1) in bambini affetti da stenosi del giunto pielo-ureterale. 131
Linea cellulare di carcinoma renale e suo uso 131
IL-12p70 and IL-18 gene-modified dendritic cells loaded with tumor antigen-derived peptides or recombinant protein effectively stimulate specific Type-1 CD4+ T-cell responses from normal donors and melanoma patients in vitro. 130
gp100/pmel17 and tyrosinase encode multiple epitopes recognized by Th1-type CD4+T cells. 130
Renal expression and urinary concentration of EGF and IL-6 in acutely dysfunctioning kidney transplanted patients 130
Proteomic profile of CD24+ CD133+ renal multipotent progenitors (RMP) 129
Altered phosphorylation of cytoskeleton proteins in peripheral blood mononuclear cells characterizes chronic antibody-mediated rejection in kidney transplantation 126
Biosimilar: can we manage biopharmaceutical heterogeneity? 125
JAK3/STAT5/6 pathway alterations are associated with immune deviation in CD8+ T cells in renal cell carcinoma patients 125
MAGE-6 encodes HLA-DRbeta1*0401-presented epitopes recognized by CD4+ T cells from patients with melanoma or renal cell carcinoma. 124
Espressione renale di PAI-1 (Plasminogen activator inhibitor-1) ed angiotensinogeno (AGT) in bambini con nefropatia ostruttiva (NO). 124
Urine profiling by SELDI-TOF/MS: Monitoring of the critical steps in sample collection, handling and analysis 124
Salivary proteomic signatures of oral squamous cell carcinoma. 124
Reclassification of glomerulopathies: which role for the podocyte? 123
Tissue factor, plasminogen activator inhibitor-1, and thrombin receptor expression in human crescentic glomerulonephritis 123
Urine protein profile of IgA nephropathy may predict the response to ACE-inhibitor therapy 123
Beyond pre-analytical and analytical concerns in the study of synovial fluid proteome: Description of an optimized gel-based protocol 123
Diagnostic and prognostic markers of renal cell carcinoma 122
Cultured human mesangial cells produce both type 1 and type 2 plasminogen activators inhibitors 121
Urinary epidermal growth factor concentration in patients affected by ADPKD. 120
Monocyte chemotactic peptide-1 expression and monocyte infiltration in acute renal transplant rejection 120
Monocyte recruitment in cryoglobulinemic membranoproliferative glomerulonephritis: a pathogenetic role for monocyte chemotactic peptide-1. 120
Altered expression of the clock gene machinery in kidney cancer patients 120
POTENTIAL SALIVARY PROTEOMIC MARKERS OF ORAL SQUAMOUS CELL CARCINOMA 120
CD40 cross-linking induces migration of renal tumor cell through nuclear factor of activated T cells (NFAT) activation 120
PROTEOMICA E RENE UN APPROCCIO INNOVATIVO ALLO STUDIO DELLE MALATTIE RENALI 119
Expression of epidermal growth factor and its receptor in normal and diseased human kidney: an immunihistochemistry and in situ study. 119
Is Berger's disease a hereditary nephritis? 119
Chronic rhinosinusitis with nasal polyposis (CRSwNP): the correlation between expression of Galectin-10 and Clinical-Cytological Grading (CCG) 119
Influence of hemodialysis on interleukin-6 production and gene expression by peripheral blood mononuclear cells. 119
Monitoring antitumor efficacy of rapamycin in Kaposi sarcoma. 118
Growth factors and their receptors in the progression of renal damage. 118
Monitoring biological action of rapamycin in renal transplantation. 118
Immunologic Response to RCC. 117
MCP-1 and EGF renal expression and urine excretion in human congenital obstructive nephropathy 117
In vitro immunogobulin production in relatives of patients with IgA Nephropathy. 116
Translational mini-review series on vaccines: Dendritic cell-based vaccines in renal cancer. 115
Pentraxin 3: A Novel Biomarker for Predicting Progression from Prostatic Inflammation to Prostate Cancer. 114
The pathogenic role of PI3K/AKT pathway in cancer onset and drug resistance: an updated review 114
Disease-associated bias in T helper type 1(Th1)/Th2 CD4(+) T cell responses against MAGE-6 in HLA-DRB10401(+) patients with renal cell carcinoma or melanoma. 113
Expression of platelet derived growth factor receptors in normal and diseased human kidney: an immunohistochemistry and in situ study. 111
Ischemia-reperfusion injury-induces abnormal dendritic cell traffic in the transplanted kidney with delayed graft function 111
Ramipril inhibits in vitro human mesangial cell proliferation and platelet-derived growth factor expression. 111
Exposure to low- vs. iso-osmolar contrast agents induces NADPH-dependent Reactive Oxygen Species (ROS) genereration in a cellular model of renal injur 111
TLR7 and TLR8 as targets for tumor immunotherapy 111
Platelet-derived growth factor and proliferative glomerulonephritis. 110
Profiles of immunoregolatory cytokine production in vitro in patients with IgA nephropathy and their kindred 108
Urinary IL-6/EGF ratio: a useful prognostic marker for the progression of renal damage in IgA nephropathy 108
REVERSE TRANSCRIPTASE INHIBITORS INDUCE CELL DIFFERENTIATION AND ENHANCE THE IMMUNOGENIC PHENOTYPE IN HUMAN RENAL CELL CARCINOMA 107
Rapamycin Inhibits PAI-1 Expression and Reduces Interstitial Fibrosis and Glomerulosclerosis in Chronic Allograft Nephropathy 107
Saliva analysis by Surface Enhanced laser Desorption/Ionization Time of Flight Mass Spectrometry (SELDI-TOF/MS): from sample collection to data analysis 107
Ischemia-reperfusion induces glomerular and tubular activation of pro-inflammatory and anti-apoptotic pathways: differential modulation by rapamycin. 107
VHL gene alterations in Italian patients with isolated renal cell carcinomas. 107
Cytotoxic T-Cells Methods and Protocols Preface 106
LPS removal reduces CD80-mediated albuminuria in critically ill patients with Gram-negative sepsis 106
Identification of naturally processed and HLA-presented Epstein-Barr virus peptides recognized by CD4(+) or CD8(+) T lymphocytes from human blood. 105
Immature myeloid and plasmacytoid dendritic cells infiltrate renal tubulointerstitium in patients with lupus nephritis. 105
Totale 13.999
Categoria #
all - tutte 116.607
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 116.607


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022982 0 14 16 33 119 46 41 79 187 139 39 269
2022/20234.250 372 177 237 274 257 365 42 312 1.957 54 88 115
2023/20241.056 120 34 49 23 73 387 58 87 17 14 14 180
2024/20253.410 196 47 113 103 125 454 481 268 815 175 334 299
2025/20265.708 322 509 556 690 277 214 1.317 590 432 407 155 239
2026/2027484 113 371 0 0 0 0 0 0 0 0 0 0
Totale 22.284